Skip to main content
Premium Trial:

Request an Annual Quote

GeneNews Truncates Offering Due to Market Conditions

NEW YORK (GenomeWeb) – GeneNews today said that it is closing its previously announced C$3 million ($2.2 million) offering after raising C$721,000 ($532,000) in gross proceeds.

James Howard-Tripp, chairman and CEO of the Toronto-based diagnostic firm, said in an announcement that it decided to truncate the offering due to current market conditions. At the initiation of the offering, GeneNews shares were trading at about C$.50 per share, but have since seen "considerable pricing pressure. We do not believe it is in the interests of either our shareholders or the company to leave the offering open over the holidays," he said.

He added that the firm will continue on its operational plan, which includes enrolling NueHealth physicians, growing revenues, and building up its roster of healthcare groups using the firm's early cancer diagnostic tests.

GeneNews had sought to raise C$3 million from a brokered private placement of convertible unsecured debentures. Net proceeds from the sale of the debentures will go toward repayment of current debt and payables, and to launch new products, the firm said.

GeneNews raised C$1.6 million in September from a private placement of stock and warrants.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.